Literature DB >> 14559791

Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex.

Hyungsoo Kim1, Ji-Eun Lee, Eun-Jung Cho, Jun O Liu, Hong-Duk Youn.   

Abstract

Menin, a gene product of multiple endocrine neoplasia type I (MEN1), is known to act as a tumor suppressor to repress JunD transcription factor. However, the mechanism by which Menin represses JunD transcriptional activity was still unclear. In this study, we found that Menin is a corepressor against JunD transcriptional activity via recruitment of histone deacetylases in an mSin3A-dependent manner. The amino acid search revealed that central domain of Menin includes a alpha-helical mSin3-interacting domain [SID (371-387)]. The SID mutation of Menin (L381P/A385P) abolished the interaction between mSin3A and paired amphipathic helix 2 domain of Menin and reduced its ability to repress JunD transcriptional activity, implicating that SID of Menin is important for recruiting an mSin3A-histone deacetylase complex to repress JunD transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559791

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  69 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

2.  Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Lucie Canaff; Jean-François Vanbellinghen; Hiroshi Kaji; David Goltzman; Geoffrey N Hendy
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival.

Authors:  Jan-Hermen Dannenberg; Gregory David; Sheng Zhong; Jaco van der Torre; Wing H Wong; Ronald A Depinho
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

Review 4.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

5.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

6.  Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein.

Authors:  Marcelo J Murai; Maksymilian Chruszcz; Gireesh Reddy; Jolanta Grembecka; Tomasz Cierpicki
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

7.  MEN1 family with a novel frameshift mutation.

Authors:  V Nuzzo; L Tauchmanová; A Falchetti; A Faggiano; F Marini; S Piantadosi; M L Brandi; L Leopaldi; A Colao
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

8.  Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Authors:  Ping La; Yuqing Yang; Satyajit K Karnik; Albert C Silva; Robert W Schnepp; Seung K Kim; Xianxin Hua
Journal:  J Biol Chem       Date:  2007-08-31       Impact factor: 5.157

9.  Direct binding of DNA by tumor suppressor menin.

Authors:  Ping La; Albert C Silva; Zhaoyuan Hou; Haoren Wang; Robert W Schnepp; Nieng Yan; Yigong Shi; Xianxin Hua
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

10.  Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model.

Authors:  Molly C Kottemann; Allen E Bale
Journal:  DNA Repair (Amst)       Date:  2009-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.